Trademark applications and grants for Actelion Pharmaceuticals L T D. Actelion Pharmaceuticals L T D has 117 trademark applications. The latest application filed is for "OCYNTIO"
Patent Application | Date |
---|---|
PHARMACEUTICAL DOSAGE SYSTEM 20220296468 - 17/697007 Mayne; Andrew ;   et al. | 2022-09-22 |
METHODS OF TREATING MULTIPLE SCLEROSIS 20220273623 - 17/628387 BURCKLEN; Michel ;   et al. | 2022-09-01 |
MACITENTAN FOR USE IN TREATING PORTOPULMONARY HYPERTENSION 20220257595 - 17/601123 PERCHENET; Loic ;   et al. | 2022-08-18 |
TRANSITIONING PATIENTS TREATED FOR PULMONARY ARTERIAL HYPERTENSION TO SELEXIPAG 20220257594 - 17/612014 ZHAO; Carol ;   et al. | 2022-08-18 |
Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension 20220096476 - 17/515132 Csonka; Denes ;   et al. | 2022-03-31 |
NCAGE Code | SUU77 | ACTELION PHARMACEUTICALS LTD |
CAGE Code | SUU77 | ACTELION PHARMACEUTICALS LTD |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.